Discovery of treatment for nerve agents targeting a new metabolic pathway

Thumbnail Image

Files

Glaros2020_Article_DiscoveryOfTreatmentForNerveAg.pdf (8.91 MB)
204_2020_2820_MOESM1_ESM.pdf (402.52 KB)

Links to Files

https://link.springer.com/article/10.1007/s00204-020-02820-4

Permanent Link

https://doi.org/10.1007/s00204-020-02820-4
 http://hdl.handle.net/11603/19452

Collections

UMBC Chemical, Biochemical & Environmental Engineering Department
UMBC Faculty Collection
UMBC Student Collection

Author/Creator

Author/Creator ORCID

Date

2020-07-27

Type of Work

journal articles
Text

Department

Program

Citation of Original Publication

Glaros, Trevor; Dhummakupt, Elizabeth S.; Rizzo, Gabrielle M.; McBride, Ethan; Carmany, Daniel O.; Wright, Linnzi K. M.; Forster, Jeffry S.; Renner, Julie A.; Moretz, Ruth W.; Dorsey, Russell; Marten, Mark R.; Huso, Walker; Doan, Alexander; Dorsey, Carrie D.; Phillips, Christopher; Benton, Bernard; Mach, Phillip M.; Discovery of treatment for nerve agents targeting a new metabolic pathway; Archives of Toxicology volume 94, pages3249–3264(2020); https://link.springer.com/article/10.1007/s00204-020-02820-4

Rights

This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
Attribution 4.0 International (CC BY 4.0)

Subjects

Abstract

The inhibition of acetylcholinesterase is regarded as the primary toxic mechanism of action for chemical warfare agents. Recently, there have been numerous reports suggesting that metabolic processes could significantly contribute to toxicity. As such, we applied a multi-omics pipeline to generate a detailed cascade of molecular events temporally occurring in guinea pigs exposed to VX. Proteomic and metabolomic profiling resulted in the identification of several enzymes and metabolic precursors involved in glycolysis and the TCA cycle. All lines of experimental evidence indicated that there was a blockade of the TCA cycle at isocitrate dehydrogenase 2, which converts isocitrate to α-ketoglutarate. Using a primary beating cardiomyocyte cell model, we were able to determine that the supplementation of α-ketoglutarate subsequently rescued cells from the acute effects of VX poisoning. This study highlights the broad impacts that VX has and how understanding these mechanisms could result in new therapeutics such as α-ketoglutarate.